Nevertheless, brain cyst reduction was only observed when this vaccine was administered through the intranasal route upon a challenge infection with the Type II 76K strain, and neither vaccination route induced significant enhancements to CD8+ T cell proliferation [12]. The gene discussed is CD8A; the disease is infection.